蔡 明, 杨得娟, 胡飞翔. Scheduling of chemotherapy based on direct monitoring of pO2 in tumor microenvironment by EPR oximetry[J]. China Oncology, 2016, 26(7): 589-595.
蔡 明, 杨得娟, 胡飞翔. Scheduling of chemotherapy based on direct monitoring of pO2 in tumor microenvironment by EPR oximetry[J]. China Oncology, 2016, 26(7): 589-595. DOI: 10.19401/j.cnki.1007-3639.2016.07.005.
Background and purpose: Tumor microenvironment plays an important role in the introduction of foreign factors that mediate tumor acquired resistance. The antitumor effects of many chemotherapeutic agents depend on the level of oxygen pressure (pO
2
) in tumor microenvironment. This study aimed to evaluate electron paramagnetic resonance (EPR)-based monitoring on
an oxygen-enriched tumor microenvironment to increase chemotherapeutic sensitivity. Methods: MCF-7 cells were used to establish human breast cancer in nude mice. EPR was used to directly measure pO
2
level in vivo. Tumor tissues were collected
and mitochondrial activity was assayed on the basis of the kinetics of enzyme-catalyzed reactions. A laser Doppler monitor was used to detect regional blood flow. Tumor apoptotic rate was analyzed by flow cytometry. Results: The tumor volume decreased more evidently in the chemotherapy group with oxygen- enriched environment than that in the conventional chemotherapy group after the treatment was administered (P0.01). After chemotherapy was completed
the apoptotic rate of tumor cells was significantly higher in the chemotherapy group with oxygen-enriched environment than that in the conventional chemotherapy group (P0.001). This study examined the mechanism of pO
2
changes in tumor microenvironment: This was related to the change of the balance between the oxygen consumption and the regional blood flow in the tumor tissues after chemotherapy. Conclusion: Based on the characteristics of pO
2
changes in the tumor microenvironment after chemotherapy was completed
the selection of chemotherapy mode for the treatment in pO
2
peak time window improves the sensitivity of chemotherapy
which provides a new idea for individualized chemotherapy in clinical applications.